Vera Deneer

Associate Professor

Strategic program(s):

Research groups

Clinical pharmacy research

Research aim

The mission of the clinical pharmacy program is to explain, predict and improve patients’ response to pharmacotherapeutic treatment using clinical pharmacological and clinical pharmacoepidemiological approaches.

Go to group

Recent publications

Associatie tussen genetische varianten en oesofagitis bij NSCLC-patiënten behandeld met platinahoudend chemotherapie en radiotherapie Leanne Ambrosio, Carlien Kamerling, Corine D.C. de Jong, Judith G.J.M. Herder, Toine A.C.G. Egberts, Vera V.H.M. Deneer
Pharmaceutisch Weekblad, 2025, vol. 160, p.19-24
Pharmacogenetic Implementation Studies—Lessons Learned From the PREPARE Study Henk Jan Guchelaar, Cathelijne H. van der Wouden, Lisanne E.N. Manson, Heshu Abdullah-Koolmees, Kathrin Blagec, Tanja Blagus, Stefan Böhringer, Erika Cecchin, Ka Chun Cheung, Vera H.M. Deneer, Siv Jonsson, Candace Joefield-Roka, Katja S. Just, Mats O. Karlsson, Lidija Konta, Rudolf Koopmann, Marjolein Kriek, Thorsten Lehr, Christina Mitropoulou, Victoria Rollinson, Rossana Roncato, Matthias Samwald, Elke Schaeffeler, Maria Skokou, Matthias Schwab, Daniela Steinberger, Julia C. Stingl, Roman Tremmel, Richard M. Turner, Mandy H. van Rhenen, Cristina L. Dávila-Fajardo, Vita Dolžan, George P. Patrinos, Munir Pirmohamed, Gere Sunder-Plassmann, Giuseppe Toffoli, Jesse J. Swen,
Clinical Pharmacology and Therapeutics, 2025, vol. 118, p.803-812
Methods in dynamic treatment regimens using observational healthcare data David Liang, Animesh Kumar Paul, Daniala L. Weir, Vera H.M. Deneer, Russell Greiner, Arno Siebes, Helga Gardarsdottir
Computer Methods and Programs in Biomedicine, 2025, vol. 263
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between SLCO1B1 and statins and CYP2C9 and sulfonylureas David F.G.J. Wolthuis, Marga Nijenhuis, Bianca Soree, Nienke J. de Boer-Veger, Anne Marie Buunk, Henk Jan Guchelaar, Arne Risselada, Gerard A.P.J.M. Rongen, Ron H.N. van Schaik, Jesse J. Swen, Daan J. Touw, Roos van Westrhenen, Vera H.M. Deneer, Elisa J.F. Houwink
European Journal of Human Genetics, 2024, vol. 33, p.413–420
Risicogestuurde benadering overtroeft de dubbelcheck A. van de Plas, W. J. Tanis, V. H.M. Deneer, G. Olsder, M. J. van der Lee, N. G.M. Hunfeld, M. Duyvendak, F. Karapinar-Çarkit, R. Rennenberg, P. M.L.A. van den Bemt
Pharmaceutisch Weekblad, 2024, vol. 159, p.19-21
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP2C19 and non-SSRI/non-TCA antidepressants Lianne Beunk, Marga Nijenhuis, Bianca Soree, Nienke J. de Boer-Veger, Anne Marie Buunk, Henk Jan Guchelaar, Elisa J.F. Houwink, Arne Risselada, Gerard A.P.J.M. Rongen, Ron H.N. van Schaik, Jesse J. Swen, Daan Touw, Vera H.M. Deneer, Roos van Westrhenen
European Journal of Human Genetics, 2024, vol. 32, p.1371-1377

External positions

Lid wetenschappelijke adviesraad - zie bijlage - Hartstichting

Associate professor klinische farmaocologie, Departement Farmaceutische Wetenschappen, UU - Onderzoek en onderwijs - Universiteit Utrecht

Lid van college ter beoordeling van geneesmiddelen - Veel raakvlakken met functie van secretaris van Geneesmiddelcommissie en functioneren als ziekenhuis - CBG